CNTA 241220 15.00P (CNTA241220P15000) Stock Options, News & Quotes

US OptionsDetailed Quotes

CNTA241220P15000

Watchlist

0.05
-0.85-94.44%

15min DelayClose Dec 2 16:00 ET

0.05High0.05Low

Intraday

5D
Daily

News

Is Centessa Pharmaceuticals (NASDAQ:CNTA) Using Too Much Debt?
Simply Wall StDec 2 07:25 ET
Insider Sale: Chief Executive Officer of $CNTA (CNTA) Sells 1,671 Shares
Quiver QuantitativeNov 22 17:17 ET
Maximus Reports Weak Earnings, Joins Atkore, PDD Holdings And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
BenzingaNov 21 07:28 ET
Leerink Partners Maintains Centessa Pharmaceuticals(CNTA.US) With Buy Rating, Announces Target Price $24
Moomoo NewsNov 20 12:31 ET · Ratings
Centessa Pharmaceuticals Is Maintained at Buy by Guggenheim
Dow JonesNov 15 14:13 ET · Ratings
Guggenheim Maintains Centessa Pharmaceuticals(CNTA.US) With Buy Rating, Raises Target Price to $28
Moomoo NewsNov 15 09:31 ET · Ratings

Comments

Stock_Drift

Sep 26 05:05

$Centessa Pharmaceuticals (CNTA.US)$

Trytosaveabit

Apr 23 15:37

Update

$Centessa Pharmaceuticals (CNTA.US)$ Press Release: Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
Dow Jones· 15 mins ago
Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
BOSTON and LONDON, April 23, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for p...

Trytosaveabit

Apr 22 06:10

Update

$Centessa Pharmaceuticals (CNTA.US)$ The FDA Has Cleared Centessa Pharmaceuticals' Investigational New Drug Application To Initiate A Phase 1 First-in-human, Clinical Trial Of ORX750 For Narcolepsy

Meltyy

Apr 2 22:13

Gear up for AACR24!

See Biotech companies with cancer assets 👇
⇨ held by 5 biopharma-focused hedge funds! 🔥
$Arcellx (ACLX.US)$ : Anito-cel (Ph 2)
$Adaptimmune Therapeutics (ADAP.US)$ : Afami-cel (PDUFA) ⏳
$Bicycle Therapeutics (BCYC.US)$ : BT8009 (Ph 1/2)
$Centessa Pharmaceuticals (CNTA.US)$ : LB101 (Ph 1/2)
$Day One Biopharmaceuticals (DAWN.US)$ : Tovorafenib (PDUFA) (check comments for details)
$Fate Therapeutics (FATE.US)$ : FT576 (Ph 1)
$Fusion Pharmaceuticals (FUSN.US)$ : FPI-2265 (Ph 2)
$GRCL: ...

JESSE JAMES8832

Feb 10 10:15

buy

$Centessa Pharmaceuticals (CNTA.US)$